Does King Charles have Sausage Digits (dactylitis) or OA? https://t.co/mRis21OWKH https://t.co/mRis21OWKH https://t.co/TmPDKu6ARh

Prevalence and Mortality of IgG4-related disease in the USA A review of the epidemiology of IgG4-RD in the USA shows a low prevalence with possibly increasing numbers, owing to increasing awareness of this unique immune-mediated condition. https://t.co/umWCPX4ing https://t.co/ZIButYrtp0

Romosuzumab and Low Sclerostin Levels Underlie CV Risk New research highlights potential safety concerns around women taking romosozumab, a new anti-osteoporosis drug available on the NHS. https://t.co/tRGOXrm0Fk https://t.co/ebiRpCC81p

Contratulations to Dr Germain Honvo (Univ. of Abomey-Calavi, Univ. Liège/Belgium) in receiving the 2023 Pierre Meunier Young Scientist Award from ESCEO & the International Osteoporosis Foundation (IOF) for his work in osteoarthritis, aging & locomotion https://t.co/gOB6VfP9vn https://t.co/SBbexkty4F

Clinical overview of subacromial pain syndr (SAPS) Brit J Sports Med. SAPS has heterogeneous causes; Dx by physical examination and imaging. Need to exclude glenohumeral OA, frozen shoulder, GH instability, rotator cuff tears, neuro & cervical disorders https://t.co/d77kXa2qSi https://t.co/vBF0692huh

DDW 2023 study claims microscopic colitis (MC) pts had a 2fold higher risk of #RA. 11,293 MC pts matched 1:5 w/ population controls. With 8 yrs of F/U, RA was found in 1.1% of MC vs 0.6% controls (adj HR 1.92 (95% CI = 1.56-2.34). https://t.co/R5faYDoaAq https://t.co/qiaOMgOyLR

REMIT-UC: Tofacitinib study 334 w/ Ulcerative Colitis:Clinical remission in 35%, Endoscopic remission in ~24%; & low risk (per/100PY) of serious infections (2.1), H zoster (0.5), & VTE (1.1). Loss of response in 45%, but recaptured 55% w/ dose escalation https://t.co/OgQYcq9pQk https://t.co/1KtLDvkQGT

715 women w/ infertility from recurrent implantation failure were randomized to either placebo or prednisone 10 mg/d. Live birth rates were unaffected by pred (37.8% 38.8% w/ PBO; NS), but pred did increase rate of preterm deliveries (11.8% vs 5.5%; P=.04) https://t.co/ey5JDk2Xi5 https://t.co/Rcgphj147r

Treatment and Management of Neuropsychiatric Lupus On the first day of ACR State of the Art conference in Orlando, Florida, Dr. Michelle Petri reviewed the treatment and management of neuropsychiatric lupus. https://t.co/99GXxyIjLl https://t.co/Bor7R2qVtN

Stop RA trail: Plaquenil didn’t prevent RA in patient with pre clinical RA. Kevin Deane #RNL2023 ⁦@RheumNow⁩ https://t.co/gO9QKbAues https://t.co/gEpuBvDpj5

#RNL2023 @RheumNow There are a lot of RA Rx on market now - do we need more? Dr. Brenner: YES Stromal targets like LIF/LIFR, Notch3, cadherin-11 offer upstream benefits for our difficult to treat RA patients that don't respond to tradition cs/bDMARDs https://t.co/Og1vvbTRO9 https://t.co/WyqPH0lgkd